Peptide Therapeutics Mid-Year 2026: The Fastest-Moving Sector in Biotech

Peptide therapeutics are one of the fastestgrowing sectors in biotech heading into the second half of 2026. From GLP1 approvals to PCAC regulatory battles, here is a comprehensive midyear update on where the field stands and what to watch in H2 2026.

For research use only. Not for human consumption.